碧迪医疗(BDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BDX 碧迪医疗

盘后交易 06-16 17:05:12 EDT

145.16

-0.36

-0.25%

盘后145.16

+0.000.00%

16:20 EDT

最高146.89	最低144.26	成交量150.98万
今开146.57	昨收145.52	日振幅1.81%
总市值399.97亿	流通市值399.19亿	总股本2.76亿
成交额2.19亿	换手率0.55%	流通股本2.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BDX","market":"US","secType":"STK","nameCN":"碧迪医疗","latestPrice":145.16,"timestamp":1781640000000,"preClose":145.52,"halted":0,"volume":1509823,"hourTrading":{"tag":"盘后","latestPrice":145.16,"preClose":145.16,"latestTime":"16:20 EDT","volume":64978,"amount":9432204.53066,"timestamp":1781641200178,"change":0,"changeRate":0,"amplitude":0.005692},"delay":0,"changeRate":-0.0024738867509621607,"floatShares":275000000,"shares":275540427,"eps":3.985327,"marketStatus":"盘后交易","change":-0.36,"latestTime":"06-16 17:05:12 EDT","open":146.57,"high":146.89,"low":144.2601,"amount":219415191,"amplitude":0.018072,"askPrice":148.5,"askSize":40,"bidPrice":144.25,"bidSize":10,"shortable":3,"etf":0,"ttmEps":3.985327,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781654400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":-240782400000,"exchange":"NYSE","adjPreClose":145.52,"dividendRate":0.028796,"preHourTrading":{"tag":"盘前","latestPrice":145.75,"preClose":145.52,"latestTime":"09:17 EDT","volume":707,"amount":103230.73852,"timestamp":1781615869037,"change":0.23,"changeRate":0.001581,"amplitude":0.036431},"postHourTrading":{"tag":"盘后","latestPrice":145.16,"preClose":145.16,"latestTime":"16:20 EDT","volume":64978,"amount":9432204.53066,"timestamp":1781641200178,"change":0,"changeRate":0,"amplitude":0.005692},"volumeRatio":0.809129,"impliedVol":0.2581,"impliedVolPercentile":0.3108},"requestUrl":"/m/hq/s/BDX","defaultTab":"news","newsList":[{"id":"1100615927","title":"碧迪医疗英国召回部分Chloraprep消毒涂抹器批次，因包装过程存在无菌性潜在风险","url":"https://stock-news.laohu8.com/highlight/detail?id=1100615927","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100615927?lang=zh_cn&edition=full","pubTime":"2026-06-02 21:17","pubTimestamp":1780406258,"startTime":"0","endTime":"0","summary":"英国药品和健康产品管理局（MHRA）发布通告，碧迪医疗（Becton Dickinson）英国分公司正在召回特定批次的Chloraprep消毒涂抹器产品。此次召回行动源于产品在包装过程中可能存在无菌性受损的潜在风险。\n无菌性是此类医疗产品的核心安全要求，任何潜在的破坏都可能影响其有效性。碧迪医疗已启动相应程序，通知相关客户与医疗机构停止使用受影响批次的产品，并将其退回。\n公司表示，正与监管机构密切合作，以解决此问题并确保患者安全。建议医疗专业人员立即检查库存，确认是否持有需召回的产品批次。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0289739343.SGD","LU0266013472.USD","LU0289961442.SGD","LU0477156797.USD","LU0648000940.SGD","LU1854104046.USD","LU0878866978.SGD","LU1489326972.SGD","LU1894683264.USD","LU1150488135.SGD","LU0130518102.USD","LU0068578508.USD","LU0433182093.SGD","LU0985320562.USD","IE00BFXG1179.USD","LU1150488218.USD","LU1201861165.SGD","LU0162691827.USD","BK4504","LU0511384066.AUD","LU0072461881.USD","BDX","LU1854103824.USD","LU0985489474.SGD","LU0006061336.USD","LU1571399168.USD","LU0130103400.USD","BK4082","LU1894683348.USD","LU1059921491.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122903260","title":"英国药品和健康产品管理局：召回批次涉及氯己定制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1122903260","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122903260?lang=zh_cn&edition=full","pubTime":"2026-06-02 21:17","pubTimestamp":1780406237,"startTime":"0","endTime":"0","summary":"英国药品和健康产品管理局发布公告，涉及特定批次产品的召回。此次召回的产品包括容量为1毫升的2%氯己定涂抹器，以及容量为1.5毫升的2%氯己定Frepp涂抹器。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1150488218.USD","LU0289739343.SGD","LU1571399168.USD","LU0433182093.SGD","BK4504","LU1150488135.SGD","LU0477156797.USD","LU1854103824.USD","LU1854104046.USD","LU0985320562.USD","LU0266013472.USD","LU0511384066.AUD","LU0072461881.USD","LU0130518102.USD","LU0878866978.SGD","BK4588","LU0985489474.SGD","LU1894683348.USD","LU1489326972.SGD","IE00BFXG1179.USD","LU0162691827.USD","LU0068578508.USD","LU1201861165.SGD","LU1894683264.USD","LU0648000940.SGD","LU0006061336.USD","BDX","LU0289961442.SGD","LU0130103400.USD","BK4082","LU1059921491.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104283534","title":"碧迪医疗恢复美国市场Chloraprep发货，最终放行测试结果达标","url":"https://stock-news.laohu8.com/highlight/detail?id=1104283534","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104283534?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:42","pubTimestamp":1780058553,"startTime":"0","endTime":"0","summary":"碧迪医疗宣布，在完成并获得了可接受的最终放行测试结果后，已恢复其产品Chloraprep在美国市场的发货。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU0433182093.SGD","BDX","IE00BFXG1179.USD","LU0985489474.SGD","LU0477156797.USD","LU0162691827.USD","BK4588","LU1489326972.SGD","LU0072461881.USD","LU0068578508.USD","LU1854103824.USD","LU0130103400.USD","LU0130518102.USD","LU0648000940.SGD","LU0985320562.USD","LU0878866978.SGD","LU1894683348.USD","BK4082","LU1201861165.SGD","BK4585","BK4504","LU0006061336.USD","LU0289739343.SGD","LU0289961442.SGD","LU0511384066.AUD","LU1059921491.USD","LU0266013472.USD","LU1854104046.USD","LU1150488218.USD","LU1150488135.SGD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111905616","title":"碧迪医疗旗下欧洲金融实体提交文件，拟发行6亿欧元、票息3.855%、2033年到期的票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1111905616","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111905616?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:41","pubTimestamp":1778532080,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，碧迪医疗（Becton Dickinson）旗下的欧洲金融实体Becton Dickinson Euro Finance S.À R.l.，已提交了发行欧元计价票据的申请。此次发行的票据本金总额为6亿欧元，票面利率定为3.855%，到期日为2033年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156797.USD","BDX","LU1894683264.USD","LU0878866978.SGD","LU1489326972.SGD","LU0162691827.USD","LU1059921491.USD","LU1854103824.USD","LU0289739343.SGD","LU0985320562.USD","BK4504","LU0289961442.SGD","LU1150488218.USD","LU0130103400.USD","LU1571399168.USD","LU1894683348.USD","LU0985489474.SGD","LU0130518102.USD","LU0266013472.USD","LU0006061336.USD","IE00BFXG1179.USD","LU1854104046.USD","LU1201861165.SGD","LU0072461881.USD","LU0433182093.SGD","LU0648000940.SGD","BK4588","BK4585","LU0068578508.USD","BK4082","LU0511384066.AUD","LU1150488135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199836732","title":"碧迪医疗欧洲金融公司拟发行欧元计价票据，提供年度现金利息支付 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1199836732","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199836732?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:06","pubTimestamp":1778493981,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的文件，碧迪医疗旗下实体Becton Dickinson Euro Finance Sa Rl计划发行以欧元计价的票据。该票据将向投资者提供年度现金利息支付。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156797.USD","BDX","LU1894683264.USD","LU0878866978.SGD","LU1489326972.SGD","LU0162691827.USD","LU1059921491.USD","LU1854103824.USD","LU0289739343.SGD","LU0985320562.USD","BK4504","LU0289961442.SGD","LU1150488218.USD","LU0130103400.USD","LU1571399168.USD","LU1894683348.USD","LU0985489474.SGD","LU0130518102.USD","LU0266013472.USD","LU0006061336.USD","IE00BFXG1179.USD","LU1854104046.USD","LU1201861165.SGD","LU0072461881.USD","LU0433182093.SGD","LU0648000940.SGD","BK4588","BK4585","LU0068578508.USD","BK4082","LU0511384066.AUD","LU1150488135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146195164","title":"异动解读 | 碧迪医疗盘中大涨6.65%，因上调年度盈利预期且药物输送设备需求强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=1146195164","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146195164?lang=zh_cn&edition=full","pubTime":"2026-05-08 03:52","pubTimestamp":1778183574,"startTime":"0","endTime":"0","summary":"碧迪医疗今日盘中大涨6.65%，引起了市场的广泛关注。消息面上，公司上调了2026财年盈利预期，预计调整后每股收益将在12.52美元至12.72美元之间，高于此前预测的12.35美元至12.65美元。此次上调主要得益于其药物输送装置和外科设备需求的强劲增长，尤其是GLP-1类注射型糖尿病及肥胖症药物的旺盛需求，持续推动了相关给药设备的销售。管理层在近期沟通中也释放出下半年营收增长态势将与上半年保持相似的稳定信号，进一步增强了投资者信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157932200","title":"碧迪医疗高管预计下半年营收增速将与上半年大致持平","url":"https://stock-news.laohu8.com/highlight/detail?id=1157932200","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157932200?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:20","pubTimestamp":1778156413,"startTime":"0","endTime":"0","summary":"在最新电话会议中，碧迪医疗管理层透露，公司预期下半年的收入增长态势将与上半年保持相似水平。这一展望表明企业运营节奏趋于稳定，市场扩张策略正按计划推进。管理层对当前业务动能持审慎乐观态度，强调将继续通过产品创新与全球市场渗透维持增长惯性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006061336.USD","LU0985489474.SGD","LU1854103824.USD","LU0511384066.AUD","LU1894683264.USD","LU1150488218.USD","LU0985320562.USD","LU0068578508.USD","LU0648000940.SGD","LU0266013472.USD","BK4504","BDX","LU1894683348.USD","LU0477156797.USD","LU1489326972.SGD","BK4585","BK4588","IE00BFXG1179.USD","LU0433182093.SGD","LU0162691827.USD","LU1571399168.USD","LU1150488135.SGD","BK4082","LU0130103400.USD","LU1059921491.USD","LU1854104046.USD","LU0878866978.SGD","LU1201861165.SGD","LU0130518102.USD","LU0072461881.USD","LU0289961442.SGD","LU0289739343.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165451424","title":"财报前瞻｜碧迪医疗本季度营收预计下降12.80%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1165451424","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165451424?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:44","pubTimestamp":1777509878,"startTime":"0","endTime":"0","summary":"碧迪医疗将于2026年05月07日美股盘前发布新一季财报，市场聚焦资产重塑后营收与盈利质量的变化及新品放量节奏。市场一致预期本季度碧迪医疗营收约46.69亿美元，同比下降12.80%；调整后每股收益约2.78美元，同比下降15.39%；由于工具未提供本季度毛利率、净利率与净利润的明确预测，相关预测项不予展示。上季度公司营收52.52亿美元，同比增长1.63%；毛利率45.91%；归母净利润3.82亿美元，净利率7.27%；调整后每股收益2.91美元，同比下降15.16%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜碧迪医疗本季度营收预计下降12.80%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199018644","title":"碧迪医疗高管称公司将继续在高增长领域推进补强型并购——巴克莱会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1199018644","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199018644?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:52","pubTimestamp":1773147136,"startTime":"0","endTime":"0","summary":"在巴克莱会议上，碧迪医疗高管透露，公司战略将聚焦于高增长领域，持续推行补强型并购策略。这一动向表明，该医疗技术巨头正通过精准收购强化核心业务布局，以捕捉新兴市场机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072461881.USD","LU0648000940.SGD","LU0433182093.SGD","LU1894683264.USD","BK4588","LU0068578508.USD","LU1489326972.SGD","LU1571399168.USD","LU0266013472.USD","IE00BFXG1179.USD","LU0985320562.USD","LU1059921491.USD","BK4082","BDX","LU1150488218.USD","LU1201861165.SGD","LU0985489474.SGD","LU0289739343.SGD","LU0511384066.AUD","BK4585","LU1854104046.USD","LU1854103824.USD","BK4504","LU0289961442.SGD","LU1150488135.SGD","LU0006061336.USD","LU1894683348.USD","LU0878866978.SGD","LU0162691827.USD","LU0130103400.USD","LU0130518102.USD","LU0477156797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161042125","title":"碧迪医疗高管透露中东业务占比低于2%，强调该地区业绩贡献强劲——巴克莱银行确认","url":"https://stock-news.laohu8.com/highlight/detail?id=1161042125","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161042125?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:44","pubTimestamp":1773146654,"startTime":"0","endTime":"0","summary":"碧迪医疗（Becton Dickinson）一位高管近日在巴克莱银行会议上表示，公司在中东地区的业务风险敞口控制在2%以内。尽管占比有限，该高管特别强调，中东市场一直是公司业绩增长的强劲推动力。\n这一表态凸显了碧迪医疗在全球战略布局中对新兴市场的重视。虽然中东业务规模相对较小，但其稳定的贡献能力成为公司整体业绩的重要支撑。分析认为，在全球化运营背景下，区域市场的均衡发展对企业抗风险能力具有关键意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU0130103400.USD","BK4504","LU1150488218.USD","LU1894683348.USD","LU0006061336.USD","BK4588","LU1571399168.USD","BK4082","LU0072461881.USD","LU0477156797.USD","LU0162691827.USD","LU0289739343.SGD","BDX","LU0985320562.USD","LU1894683264.USD","LU0511384066.AUD","LU0648000940.SGD","LU0130518102.USD","LU0068578508.USD","LU1059921491.USD","LU0433182093.SGD","LU1150488135.SGD","LU0985489474.SGD","LU0289961442.SGD","LU0878866978.SGD","IE00BFXG1179.USD","LU1854103824.USD","LU1201861165.SGD","LU1489326972.SGD","BK4585","LU1854104046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616535160","title":"聚焦临床流式领域，碧迪医疗与迈瑞医疗达成重要合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2616535160","media":"广州日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616535160?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:35","pubTimestamp":1772616908,"startTime":"0","endTime":"0","summary":"近日，碧迪医疗生物科学与迈瑞医疗体外诊断事业部宣布正式达成重要合作。双方将聚焦临床流式领域，展开全面且深入的渠道合作，并共同为未来进一步深化品牌合作筑牢基础，携手推进中国流式业务及智慧检验整体解决方案高质量发展。流式细胞术作为现代免疫学诊断、血液病精准分型及肿瘤监测的核心技术，在临床诊疗中发挥着不可替代的作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603043661816396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B29SXG58.USD","LU0823426308.USD","LU1150488218.USD","LU0605514214.HKD","BK4588","LU0162691827.USD","LU1854104046.USD","LU0068578508.USD","LU0878866978.SGD","LU1489326972.SGD","LU1854103824.USD","LU0072461881.USD","LU1064131003.USD","LU1150488135.SGD","LU2153592121.USD","LU2348773727.SGD","LU2213484517.USD","LU1734074674.USD","LU1571399168.USD","LU0405327494.USD","BK0251","LU2153591404.USD","LU2348774022.SGD","LU0572944931.SGD","LU1894683348.USD","LU1146622755.USD","LU1720050803.USD","LU1997245177.USD","LU0266013472.USD","IE0005HP3H50.USD","LU0130103400.USD","LU1979443071.USD","LU1655091616.SGD","SGXZ81163826.USD","BDX","LU0084288322.USD","LU1023057109.AUD","300760","LU0289961442.SGD","LU1201861165.SGD","LU1794554557.SGD","LU2488822045.USD","IE0031814852.USD","LU1580142542.USD","IE00B031J352.USD","LU2148510915.USD","LU1688375341.USD","BK4082","LU1781817850.SGD","LU0594300179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137932122","title":"碧迪医疗开创外科安全新标准：FDA批准Surgiphor™ 1000毫升伤口冲洗系统","url":"https://stock-news.laohu8.com/highlight/detail?id=1137932122","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137932122?lang=zh_cn&edition=full","pubTime":"2026-03-02 19:53","pubTimestamp":1772452397,"startTime":"0","endTime":"0","summary":"碧迪医疗通过其最新获得美国食品药品监督管理局批准的Surgiphor™ 1000毫升伤口冲洗系统，为外科手术安全树立了全新标杆。这一创新产品的推出，标志着公司在提升医疗操作标准与患者安全方面迈出了重要一步。\n该系统专为高效、安全的伤口冲洗设计，旨在优化手术流程并降低感染风险。其大容量设计满足了长时间手术的需求，同时确保了冲洗过程的连贯性与稳定性。碧迪医疗此举不仅展现了其在医疗技术领域的持续创新能力，更突显了其对推动行业标准升级的坚定承诺。\n随着Surgiphor™ 1000毫升系统的推广应用，外科手术团队将能更有效地执行伤口护理，进一步提升手术安全性及患者预后效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","BDX","LU0130518102.USD","BK4082","LU0511384066.AUD","LU1571399168.USD","LU0289961442.SGD","LU1150488135.SGD","BK4585","LU1201861165.SGD","LU1150488218.USD","LU0648000940.SGD","LU1854103824.USD","LU0289739343.SGD","LU0985320562.USD","LU1489326972.SGD","LU1894683348.USD","IE00BFXG1179.USD","LU1854104046.USD","LU0878866978.SGD","LU0433182093.SGD","LU0985489474.SGD","BK4588","LU0072461881.USD","BK4504","LU0477156797.USD","LU0006061336.USD","LU0130103400.USD","LU1059921491.USD","LU0068578508.USD","LU0162691827.USD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146066033","title":"碧迪医疗公布债券回购要约定价及获接受购买金额","url":"https://stock-news.laohu8.com/highlight/detail?id=1146066033","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146066033?lang=zh_cn&edition=full","pubTime":"2026-02-26 05:16","pubTimestamp":1772054194,"startTime":"0","endTime":"0","summary":"碧迪医疗公司已正式公布其债券回购要约的具体定价条款，同时明确了获接受购买的债券总额。此次回购操作标志着公司资本管理策略的关键进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1894683348.USD","LU0648000940.SGD","LU0985489474.SGD","LU0289739343.SGD","LU0006061336.USD","LU0130518102.USD","LU0433182093.SGD","LU0266013472.USD","LU1150488135.SGD","BK4504","LU0289961442.SGD","BK4082","LU0985320562.USD","LU1059921491.USD","LU1571399168.USD","LU1854104046.USD","LU0068578508.USD","LU0162691827.USD","LU1201861165.SGD","LU0477156797.USD","IE00BFXG1179.USD","LU0511384066.AUD","LU1894683264.USD","BK4588","LU0072461881.USD","LU1854103824.USD","LU1489326972.SGD","LU0130103400.USD","LU1150488218.USD","LU0878866978.SGD","BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177877987","title":"碧迪医疗股价重挫19.8%，创1999年以来最大单日跌幅，公司下调2026年盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1177877987","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177877987?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:40","pubTimestamp":1770734439,"startTime":"0","endTime":"0","summary":"碧迪医疗股价遭遇断崖式下跌，跌幅高达19.8%，正朝着自1999年以来最严重的单日跌幅纪录迈进。此番剧烈波动源于公司突然宣布下调2026财年的利润指引，市场信心遭受重创。\n投资者纷纷抛售持仓，导致股价直线下挫。这一暴跌不仅反映了市场对碧迪医疗中长期盈利能力的担忧，更凸显出医疗器械行业面临的宏观挑战。此次下调预期可能预示着行业整体增长放缓，或公司特定业务板块面临结构性压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0068578508.USD","LU1150488218.USD","LU1854103824.USD","LU1489326972.SGD","BDX","LU1201861165.SGD","LU0433182093.SGD","LU0289739343.SGD","IE00BFXG1179.USD","LU1894683264.USD","LU1571399168.USD","LU0289961442.SGD","BK4588","LU0266013472.USD","LU0511384066.AUD","LU1854104046.USD","BK4082","LU0648000940.SGD","LU0130518102.USD","LU0130103400.USD","LU0162691827.USD","LU0477156797.USD","LU0878866978.SGD","LU1894683348.USD","LU1150488135.SGD","LU0006061336.USD","BK4504","LU0985489474.SGD","LU1059921491.USD","LU0072461881.USD","BK4585","LU0985320562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111479763","title":"异动解读 | 合并交易完成，碧迪医疗盘前大涨7.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111479763","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111479763?lang=zh_cn&edition=full","pubTime":"2026-02-10 18:41","pubTimestamp":1770720084,"startTime":"0","endTime":"0","summary":"碧迪医疗（BDX）今日盘前股价大幅上涨7.37%，引起了市场的广泛关注。消息面上，沃特世公司（WAT）宣布已完成与碧迪医疗生物科学与诊断解决方案业务的合并。此次交易通过反向莫里斯信托交易完成，缔造了一家全球生命科学与诊断领域的领导者，碧迪医疗的股东将获得沃特世的股份，交易完成后持有合并后公司39.2%的股权。市场分析认为，这项重大合并的完成可能带来协同效应和增长潜力，增强了投资者对碧迪医疗未来前景的信心，从而推动了股价的显著上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610442436","title":"近130亿元！碧迪这项业务卖了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2610442436","media":"IVD体外诊断网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610442436?lang=zh_cn&edition=full","pubTime":"2026-02-10 15:21","pubTimestamp":1770708111,"startTime":"0","endTime":"0","summary":"来源：CACLP2026年2月9日，沃特世正式完成与碧迪医疗旗下生物科学与诊断解决方案业务的合并，18.8亿美元的合并交易成交。BD股东持有合并后公司39.2%股份。管理层表示，将在整合初期重点推进BD业务与现有业务协同，并充分利用仪器更换、电子商务和服务附加等潜在增长机会。消息公布后，Waters股价在纽约证券交易所下跌12%，收于335.86美元。碧迪医疗几乎在每个国家/地区都有业务，并与世界各地的组织合作，以解决一些最具挑战性的全球健康问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021016140295408f12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021016140295408f12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0068578508.USD","LU0985489474.SGD","LU1150488135.SGD","LU0289739343.SGD","LU0130103400.USD","LU1201861165.SGD","LU1854104046.USD","LU1059921491.USD","BK4082","LU0289961442.SGD","BK4585","LU0006061336.USD","LU0878866978.SGD","LU1571399168.USD","LU1854103824.USD","LU0511384066.AUD","IE00BFXG1179.USD","LU0985320562.USD","LU0072461881.USD","LU0266013472.USD","LU1150488218.USD","LU0648000940.SGD","LU1894683264.USD","LU0162691827.USD","LU1489326972.SGD","LU0477156797.USD","LU1894683348.USD","BDX","BK4588","LU0433182093.SGD","BK4504","LU0130518102.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156462709","title":"财报前瞻｜碧迪医疗本季度营收或小幅增长，机构观点偏稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=1156462709","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156462709?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:01","pubTimestamp":1769997664,"startTime":"0","endTime":"0","summary":"碧迪医疗将在2026年02月09日发布财报，市场关注营收与盈利质量的变动及核心业务的增长韧性。一致预期显示本季度总收入预计为51.54亿美元，同比增长1.10%；调整后每股收益预计为2.85美元，同比下降4.46%；息税前利润预计为10.93亿美元，同比下降3.91%。工具数据未提供本季度毛利率与净利率预测，因而不展示相关预测信息。结合工具所示本季度的预测，机构更关注利润端的下行压力及费用投放的节奏。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜碧迪医疗本季度营收或小幅增长，机构观点偏稳健","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178029680","title":"碧迪医疗董事会宣布派发股息，授权额外回购1000万股；本财年迄今已完成2.5亿美元回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1178029680","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178029680?lang=zh_cn&edition=full","pubTime":"2026-01-28 05:15","pubTimestamp":1769548518,"startTime":"0","endTime":"0","summary":"碧迪医疗公司董事会已正式宣布派发股息，并授权一项额外的股票回购计划，规模达1000万股。与此同时，该公司在本财年迄今为止已完成了总额高达2.5亿美元的股份回购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289961442.SGD","LU1571399168.USD","LU1854104046.USD","LU1150488218.USD","BK4504","LU1894683264.USD","LU0878866978.SGD","LU0068578508.USD","LU0985320562.USD","LU1059921491.USD","LU0130518102.USD","BK4082","LU0162691827.USD","LU0130103400.USD","LU1489326972.SGD","LU0433182093.SGD","LU0477156797.USD","IE00BFXG1179.USD","BDX","LU0511384066.AUD","LU1150488135.SGD","LU0072461881.USD","LU0006061336.USD","LU0266013472.USD","LU1894683348.USD","LU0648000940.SGD","BK4585","LU0289739343.SGD","BK4588","LU1201861165.SGD","LU0985489474.SGD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605922145","title":"BD医疗任命Shawn Bevec为投资者关系高级副总裁，曾就职于强生、辉瑞","url":"https://stock-news.laohu8.com/highlight/detail?id=2605922145","media":"药械VIP","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605922145?lang=zh_cn&edition=full","pubTime":"2026-01-20 18:34","pubTimestamp":1768905270,"startTime":"0","endTime":"0","summary":"近日，全球医械巨头BD公司宣布，任命Shawn Bevec为投资者关系高级副总裁，该任命自2026年1月20日起生效。Bevec在投资者关系与股票研究领域拥有丰富经验。此前，他在Quest Diagnostics担任投资者关系副总裁，负责投资者沟通、盈利发布及相关资本市场活动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120204317a730ab87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120204317a730ab87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2133065610.SGD","IE00BVYPNV92.GBP","LU2750360997.AUD","IE00B3PB1722.GBP","IE00BN8TJ469.HKD","LU2602419157.SGD","LU0432979614.USD","LU1162221912.USD","LU0234570918.USD","SG9999013999.USD","LU0787776722.HKD","LU1057294990.SGD","LU2471134952.CNY","LU2750360641.GBP","LU0114720955.EUR","LU1894683264.USD","IE0009355771.USD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU2505996509.AUD","BK4592","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU1074936037.SGD","LU2089984988.USD","LU2112291526.USD","LU2471134879.HKD","LU1732800096.USD","IE00B42XCP33.USD","LU1061106388.HKD","LU1059921491.USD","IE00BKVL7J92.USD","SG9999003800.SGD","IE00B19Z3581.USD","LU2347655156.SGD","BDX","LU0170899867.USD","LU0882574055.USD","LU0889566641.SGD","LU2505996681.GBP","LU2471134796.USD","BK4007","BK4534","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4588","LU0345770993.USD","LU2430703178.SGD","LU0321505439.SGD","LU0098860793.USD","BK4599","IE00BFXG1179.USD","LU0225284248.USD","LU1244550221.USD","LU1914381329.SGD","LU0124676726.USD","LU0321505868.SGD","LU0225771236.USD","LU2129689514.USD","LU0689626769.HKD","IE0002270589.USD","LU0070217475.USD","LU0320765646.SGD","LU1718418525.SGD","BK4581","LU0640476718.USD","LU1032955483.USD","LU1196500208.SGD","IE00BDGV0183.EUR","LU1778281490.HKD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU1883839398.USD","LU2430703251.USD","IE00B19Z3B42.SGD","IE00B1BXHZ80.USD","LU0985320562.USD","LU2129689605.HKD","LU1267930813.SGD","SG9999001176.USD","IE00BJT1NW94.SGD","LU1221951129.SGD","LU0203345920.USD","IE00B3T34201.USD","LU1244550577.SGD","LU1244550494.USD","LU1674673428.USD","SG9999002224.SGD","LU0345769631.USD","LU0345769128.USD","LU2129689431.USD","LU1261432733.SGD","LU0466842654.USD","LU1894683348.USD","BK4568","LU2592432038.USD","LU1066053197.SGD","LU0792757196.USD","LU0985481810.HKD","IE00BLSP4239.USD","IE00BVYPNW00.USD","LU1066051498.USD","IE0034235303.USD","LU0345770308.USD","LU1066051225.USD","SG9999001440.SGD","LU0058720904.USD","LU0795875169.SGD","LU1674673691.USD","LU0795875086.SGD","BK4550","BK4559","LU0289739699.SGD","LU0683600562.USD","LU0234572021.USD","BK4533","LU1032466523.USD","IE00BLSP4452.SGD","IE00B2B36J28.USD","BK4532","IE00BFTCPJ56.SGD","SG9999011175.SGD","LU1496350502.SGD","LU2471134523.USD","LU0306807586.USD","SGXZ57979304.SGD","LU0912757837.SGD","LU1732799900.SGD","LU0306806265.USD","IE0002141913.USD","IE000M9KFDE8.USD","LU1585245621.USD","LU0868494617.USD","LU2430703095.HKD","BK4585","LU1221951046.USD","SG9999001176.SGD","LU1280957306.USD","LU1929549753.HKD","LU1066051811.HKD","SG9999002232.USD","LU0456855351.SGD","LU1023059063.AUD","LU1430594728.SGD","LU0203347892.USD","BK4504","LU1935042991.SGD","LU1506573853.SGD","IE00BGHQF631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150963854","title":"碧迪医疗交易完成日收盘后启动静默期 根据SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1150963854","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150963854?lang=zh_cn&edition=full","pubTime":"2026-01-07 05:49","pubTimestamp":1767736154,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，碧迪医疗（Becton Dickinson）将于交易完成日市场收盘后正式进入静默期。\n该静默期将限制公司内部人员及关联方在特定时间段内进行股票交易，以确保交易过程的合规性与信息公平性。这一举措通常出现在企业重大资本运作关键节点，旨在防止内幕信息不当流动。\n文件进一步明确，静默期的具体实施细节将严格遵循证券监管规定。市场分析人士指出，此类安排往往预示着公司可能即将发布重大财务数据或进行战略调整。\n随着静默期的启动，投资者需密切关注碧迪医疗后续可能披露的官方信息，以准确把握公司最新动态对股价的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU1150488135.SGD","LU1854103824.USD","LU0511384066.AUD","LU0006061336.USD","LU0878866978.SGD","LU0068578508.USD","LU0266013472.USD","LU0477156797.USD","LU0289961442.SGD","LU1059921491.USD","LU0433182093.SGD","LU0072461881.USD","LU1489326972.SGD","LU1571399168.USD","BK4588","BK4504","LU0130518102.USD","LU0648000940.SGD","LU0162691827.USD","LU0130103400.USD","LU1201861165.SGD","LU0985320562.USD","IE00BFXG1179.USD","LU0289739343.SGD","LU0985489474.SGD","LU1150488218.USD","LU1894683264.USD","LU1894683348.USD","BK4585","BDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bd.com;investors.bd.com","stockEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":0.0143},{"period":"3month","weight":-0.0997},{"period":"6month","weight":-0.2551},{"period":"1year","weight":-0.155},{"period":"ytd","weight":-0.2502}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.1253},{"period":"6month","weight":0.1243},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"碧迪医疗器械有限公司于1906年11月根据新泽西州法律注册成立。该公司是一家全球性的医疗技术公司，从事医疗机构、医生、生命科学研究人员、临床实验室、制药行业和公众使用的各种医疗用品、设备、实验室设备和诊断产品的开发、制造和销售。公司提供客户解决方案，重点是改善药物管理和患者安全；支持感染预防实践；配备手术和介入手术；改进药物输送；协助麻醉护理；加强传染病和癌症的诊断；促进细胞研究和应用；支持糖尿病的管理。","yearOnYearQuotes":[{"month":1,"riseRate":0.652174,"avgChangeRate":0.039976},{"month":2,"riseRate":0.478261,"avgChangeRate":-0.000257},{"month":3,"riseRate":0.565217,"avgChangeRate":-0.005291},{"month":4,"riseRate":0.489362,"avgChangeRate":0.003745},{"month":5,"riseRate":0.468085,"avgChangeRate":0.00916},{"month":6,"riseRate":0.595745,"avgChangeRate":0.006359},{"month":7,"riseRate":0.586957,"avgChangeRate":-0.000169},{"month":8,"riseRate":0.652174,"avgChangeRate":0.010063},{"month":9,"riseRate":0.369565,"avgChangeRate":-0.00253},{"month":10,"riseRate":0.478261,"avgChangeRate":0.005703},{"month":11,"riseRate":0.652174,"avgChangeRate":0.022144},{"month":12,"riseRate":0.695652,"avgChangeRate":0.019833}],"exchange":"NYSE","name":"碧迪医疗","nameEN":"Becton Dickinson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"碧迪医疗(BDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供碧迪医疗(BDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"碧迪医疗,BDX,碧迪医疗股票,碧迪医疗股票老虎,碧迪医疗股票老虎国际,碧迪医疗行情,碧迪医疗股票行情,碧迪医疗股价,碧迪医疗股市,碧迪医疗股票价格,碧迪医疗股票交易,碧迪医疗股票购买,碧迪医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"碧迪医疗(BDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供碧迪医疗(BDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}